Open Access18F-fluorodeoxyglucose-positron emission tomography/computed tomography in tuberculosis: Spectrum of manifestations
Author(s) -
Krishan Kant Agarwal,
Abhishek Behera,
Rakesh Kumar,
Chandrasekhar Bal
Publication year - 2017
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/ijnm.ijnm_29_17
Subject(s) - medicine , positron emission tomography , positron emission , computed tomography , fluorodeoxyglucose , positron emission tomography computed tomography , tuberculosis , nuclear medicine , tomography , radiology , positron , pathology , physics , quantum mechanics , electron
The objective of this article is to provide an illustrative tutorial highlighting the utility of 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) imaging to detect spectrum of manifestations in patients with tuberculosis (TB). FDG-PET/CT is a powerful tool for early diagnosis, measuring the extent of disease (staging), and consequently for evaluation of response to therapy in patients with TB.